Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Template:SUIT-006 NADH mt D084"

From Bioblast
 
(4 intermediate revisions by 2 users not shown)
Line 14: Line 14:
| mt
| mt


*{{Template:SUIT REN}}
*{{Template:SUIT REN NADH}}


|-
|-
Line 37: Line 37:


|-
|-
| 2c
| (3Omy)
| [[PGM]]c<sub>''[[OXPHOS|P]]''</sub>
| [[N]]
| CI
| 1PGM;2D;2c
 
*{{Template:SUIT N}}
*{{Template:SUIT OXPHOS}}
*{{Template:SUIT c}}
 
|-
| 3Omy
| [[PGM]]<sub>[[LEAK respiration|''L''(Omy)]]</sub>  
| [[PGM]]<sub>[[LEAK respiration|''L''(Omy)]]</sub>  
| [[N]]
| [[N]]
| CI
| CI
| 1PGM;2D;2c;3Omy
| 1PGM;2D;(3Omy)


* Omy addition is skipped in SUIT-006 NADH mt D084
*{{Template:SUIT N}}
*{{Template:SUIT N}}
*{{Template:SUIT L(Omy)}}  
*{{Template:SUIT L(Omy)}}  
*The addition of [[oligomycin]] is optional depending on the experimental question to resolve. If it is known that ''L''(n) has the same values for ''L''(Omy) for a kind of sample and substrates, this step may be skipped. If the carrier of oligomycin (EtOH) is used instead, it is possible to evaluate whether it affects respiration. In these cases, LEAK state is not reached again.


|-
|-
Line 63: Line 52:
| [[N]]
| [[N]]
| CI
| CI
| 1PGM;2D;2c;3Omy;4U
| 1PGM;2D;(3Omy);4U


*{{Template:SUIT N}}
*{{Template:SUIT N}}
Line 71: Line 60:
| 5Anox
| 5Anox
|  
|  
|  
| [[N]]
|
| CI
| 1PGM;2D;2c;3Omy;4U;5Anox
| 1PGM;2D;(3Omy);4U;5Anox


*{{Template:SUIT Anoxia NADH}}
*{{Template:SUIT Anoxia NADH}}
Line 80: Line 69:
| 6Myx
| 6Myx
|  
|  
|  
| [[N]]
|
| CI
| 1PGM;2D;2c;3Omy;4U;5Anox;6Myx  
| 1PGM;2D;(3Omy);4U;5Anox;6Myx  


*{{Template:SUIT Myx}}
*{{Template:SUIT Myx}}
Line 91: Line 80:
|  
|  
|   
|   
| 1PGM;2D;2c;3Omy;4U;5Anox;6Myx; Reox
| 1PGM;2D;(3Omy);4U;5Anox;6Myx;7Reox


*{{Template:SUIT Reox}}
*{{Template:SUIT Reox}}

Latest revision as of 12:01, 5 January 2024

MitoPedia: SUIT

Steps and respiratory states

Mt;1PGM;2D;3(Omy);4U;5Anox;6Myx;7Reox.png


Step State Pathway Q-junction Comment - Events (E) and Marks (M)
mt REN mt
  • Respiration in the REN state is due to the presence of residual endogenous substrates.
  • In the absence of endogenous substrates, mt can be used for calibration of fully oxidized NAD.
1PGM PGML(n) N CI 1PGM
2D PGMP N CI 1PGM;2D
(3Omy) PGML(Omy) N CI 1PGM;2D;(3Omy)
  • Omy addition is skipped in SUIT-006 NADH mt D084
  • NADH-linked substrates (type N-pathway to Q).
  • Non-phosphorylating resting state (LEAK state); LEAK-respiration, L(Omy), after blocking the ATP synthase with oligomycin.
4U PGME N CI 1PGM;2D;(3Omy);4U
5Anox N CI 1PGM;2D;(3Omy);4U;5Anox
  • Anoxia, after the biological sample has consumed the O2 in the O2k-chamber, is used to detect the fully reduced NAD for calculation of the NAD redox states.
6Myx N CI 1PGM;2D;(3Omy);4U;5Anox;6Myx
  • The addition of myxothiazol after anoxia is a crucial step to detect the fully reduced NAD for calculation of the NAD redox state. Myxothiazol can induce a further reduction of NAD under anoxia.
7Reox ROX 1PGM;2D;(3Omy);4U;5Anox;6Myx;7Reox
  • The reoxygenation by opening the chamber in the presence of Myx allows for Rox-correction of the O2 fluxes.


Questions.jpg


Click to expand or collaps